ML20155A902: Difference between revisions

From kanterella
Jump to navigation Jump to search
(StriderTol Bot insert)
 
(StriderTol Bot change)
 
Line 20: Line 20:
1 NOTICE OF VIOLATION St. Mary's Hospital                                            License No. SNM-1804 As a result of the inspection conducted on March 3-5, 1986, and in accordance with the " General Policy and Procedures for NRC Enforcement Actions," 10 CFR Part 2, Appendix C (1985), the following violation was identified:
1 NOTICE OF VIOLATION St. Mary's Hospital                                            License No. SNM-1804 As a result of the inspection conducted on March 3-5, 1986, and in accordance with the " General Policy and Procedures for NRC Enforcement Actions," 10 CFR Part 2, Appendix C (1985), the following violation was identified:
License Condition No.16 requires that licensed material be possessed and used in accordance with the statements, representations, and procedures contained in certain referenced applications and letters.
License Condition No.16 requires that licensed material be possessed and used in accordance with the statements, representations, and procedures contained in certain referenced applications and letters.
The referenced application dated January 24, 1978 and letter dated March 22, 1983 state, in part, that " Human Clinical Protocol for the Coratomic 101 Radioisotope Powered Cardiac Pacemaker," dated November 1, 1975, will be followed. This protocol states, in part, that implanted patients will receive follow-up contact at six month intervals until the pacemaker is removed.
The referenced application dated January 24, 1978 and {{letter dated|date=March 22, 1983|text=letter dated March 22, 1983}} state, in part, that " Human Clinical Protocol for the Coratomic 101 Radioisotope Powered Cardiac Pacemaker," dated November 1, 1975, will be followed. This protocol states, in part, that implanted patients will receive follow-up contact at six month intervals until the pacemaker is removed.
Contrary to this requirement, yotAhave not been contacting implanted patients at six montn intervals. Specifically, prior to May, 1985, you conducted implanted patient follow-up contact at,12 month intervals.
Contrary to this requirement, yotAhave not been contacting implanted patients at six montn intervals. Specifically, prior to May, 1985, you conducted implanted patient follow-up contact at,12 month intervals.
This is a Severity Level IV violation (Supplement VI).
This is a Severity Level IV violation (Supplement VI).

Latest revision as of 00:09, 10 December 2021

Notice of Violation from Insp on 860303-05
ML20155A902
Person / Time
Site: 07002801
Issue date: 04/04/1986
From: Axelson W
NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION III)
To:
Shared Package
ML19298D841 List:
References
70-2801-86-01, 70-2801-86-1, NUDOCS 8604100118
Download: ML20155A902 (1)


Text

_

1 NOTICE OF VIOLATION St. Mary's Hospital License No. SNM-1804 As a result of the inspection conducted on March 3-5, 1986, and in accordance with the " General Policy and Procedures for NRC Enforcement Actions," 10 CFR Part 2, Appendix C (1985), the following violation was identified:

License Condition No.16 requires that licensed material be possessed and used in accordance with the statements, representations, and procedures contained in certain referenced applications and letters.

The referenced application dated January 24, 1978 and letter dated March 22, 1983 state, in part, that " Human Clinical Protocol for the Coratomic 101 Radioisotope Powered Cardiac Pacemaker," dated November 1, 1975, will be followed. This protocol states, in part, that implanted patients will receive follow-up contact at six month intervals until the pacemaker is removed.

Contrary to this requirement, yotAhave not been contacting implanted patients at six montn intervals. Specifically, prior to May, 1985, you conducted implanted patient follow-up contact at,12 month intervals.

This is a Severity Level IV violation (Supplement VI).

Pursuant to the provisions of 10 CFR 2.201, you are required to submit to this office within thirty days of the date of this Notice a written statement or explanation in reply, including for each violation: (1) corrective action taken and the results achieved; (2) corrective action to be taken to avoid further violations; and (3) the date when full compliance will be achieved.

Consideration may be given to extending'your response time for good cause shown.

~ Dated YYb

' ~ 6 W. L. Axelson, Chief Nuclear Materials Safety and Safeguards Branch i 1 l

1 k k f g 860404 SNM-1gog I

PDR 3

l h,

J G s

. s- ~~